US Patent Issued to AlbuNext on Feb. 17 for "Albumin bound macromolecule tri-agonist activating GLP 1/GIP/glucagon receptors and methods therefor" (Canadian, American Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,541, issued on Feb. 17, was assigned to AlbuNext LLC (El Segundo, Calif.).

"Albumin bound macromolecule tri-agonist activating GLP 1/GIP/glucagon receptors and methods therefor" was invented by Patrick Soon-Shiong (Culver City, Calif.), Martin Robitaille (Saint-Colomban, Canada) and Bing Song (El Segundo, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A pharmaceutical composition comprises a GPCR agonist fusion protein in which a GPCR agonist peptide is covalently coupled to albumin via a linker in a manner that is resistant to a retro-Michael addition. Advantageously, compositions presented herein avoid decoupling of the agonist form the alb...